Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. EyePoint Pharmaceuticals, Inc.
FDA Inspection
•EyePoint Pharmaceuticals, Inc.•August 28, 2019

EyePoint Pharmaceuticals, Inc. – FDA Inspection, Aug 28, 2019

Record Details

This FDA Inspection record concerns EyePoint Pharmaceuticals, Inc., with an inspection on August 28, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
EyePoint Pharmaceuticals, Inc.
Inspection Date
August 28, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Chhaya S. Shetty (Issuing Officer)
  • Erik W. Koester (FDA Associated Person)
View Company Profile

ID · bd40ecfd-6d7a-4c39-8319-1d042041f48b

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1102130
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

9
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
  3. 21 CFR 211.42(c)(10)(v)Cleaning System
  4. 21 CFR 211.110(b)In-process materials specifications testing
  5. 21 CFR 211.84(d)(2)Reports of Analysis (Components)
  6. 21 CFR 211.68(a)Calibration/Inspection/Checking not done
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.22(d)Procedures not in writing, fully followed
  9. 21 CFR 211.192No written record of investigation

Full citation text and observation details available on the Dashboard.

Other FDA inspections of EyePoint Pharmaceuticals, Inc.

4
DateClassificationOfficeProject area
February 15, 2024Not classifiedNew England District OfficeDrug Quality Assurance
September 1, 2021VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 19, 2018Not classifiedNew England District Office
April 4, 2018OAINew England District OfficeNew Drug Evaluation
Other documents for EyePoint Pharmaceuticals, Inc.
  • FDA Inspection 1230113 - 2024-02-15
  • FDA Inspection 1150669 - 2021-09-01
  • FDA Inspection 1067552 - 2018-09-19
  • FDA Inspection 1046783 - 2018-04-04

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore EyePoint Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.